This project will use linked administrative data to understand risk for mortality and other adverse outcomes during and after opioid agonist treatment (OAT). It will use standard biostatistical approaches and sophisticated machine learning techniques.
Treatment and Intervention
This project attempts to understand the global epidemiology of infectious disease among prisoners in all countries.
Alcohol and other drug (AOD) treatment is key for improving health and reducing the social impact of AOD use. However, the treatment itself is not the only variable that impacts on whether health outcomes are improved.
This project seeks to develop knowledge about effective models of partnership between rural Aboriginal communities and researchers across a range of community-led programs delivered from 2012-2016, which aimed to reduce drug and alcohol-related harm.
This project will review the evidence for the medicinal use of cannabis and cannabinoid products for a number of key medical conditions.
Substance use among pregnant women is a significant public health issue. A range of adverse effects have been noted including increased risk of miscarriage and still birth, reduction in fetal growth, birth defects, developmental delay, growth retardation and neurological abnormalities.
The monograph is an outcome of the Intergovernmental Committee on Drugs (IGCD) Fetal Alcohol Spectrum Disorder (FASD) Working Party.
Australian surveys of those with cannabis use disorder (CUD) reveal that general medical practitioners (GPs) are the preferred source of treatment as they are seen as trust worthy and confidential.